Article
249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients.
BMC cancer - 26 Jun 2009
Nogueira Jeronimo A, Ono-Nita Suzane K, Nita Marcelo E, de Souza Marcelo M T, do Carmo Eliane P, Mello Evandro S, Scapulatempo Cristovan, Paranaguá-Vezozzo Denise C, Carrilho Flair J, Alves Venancio A F
Abstract excerpt
BACKGROUND: Ser-249 TP53 mutation (249(Ser)) is a molecular evidence for aflatoxin-related carcinogenesis in Hepatocellular Carcinoma (HCC) and it is frequent in some African and Asian regions, but it is unusual in Western countries. HBV has been claimed to add a synergic effect on genesis of thi...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
